financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Reliance, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Reliance, Inc.
Apr 26, 2024 1:19 PM

03:45 PM EDT, 04/26/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We decrease our 12-month target by $17 to $313, which assumes an EV/EBITDA of 10.0x our 2024 EBITDA estimate, at the upper end of the three-year range of RS's forward EV/EBITDA (4.5x-11.3x). Our DCF model shows significant upside (40%+) to RS's intrinsic value, but we are concerned about RS's relative valuation, trading at a 40% premium to peers on forward EV/EBITDA. We lower our 2024 EPS estimate by $1.44 to $19.79, but increase our 2024 EPS estimate by $1.89 to $21.08. RS posted Q1 adj. EPS of $5.30 vs. $6.37, $0.21 below consensus; Q1 revenue was down 8% Y/Y and missed consensus by 3%. During Q1, total tons sold fell 1.7% Y/Y (down 2.9% Y/Y organically) and the average selling price per ton fell 6.9% Y/Y to $2,442/ton. We anticipate a rebound in volume, with sequential growth in volume in Q2 of around 3%. We continue to be impressed with RS's resilient gross margin, which was 31.0% in Q1, up 10 basis points Y/Y. However, RS's premium valuation keeps us on the sidelines, as we see limited upside in 2024.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Buy Opinion On Shares Of O'reilly Automotive Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of O'reilly Automotive Inc.
Jul 8, 2025
12:30 PM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We are updating our price target for the company's recently-completed 15-for-1 stock split. As a result, our price target goes to $100 from $1,500, based on a 2026 P/E of...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Amphenol Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Amphenol Corporation
Jul 8, 2025
11:30 AM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $110 from $85, shifting to a P/E of 37x our 2026 EPS view, above APH's three-year average (~28x) on sizeable AI tailwinds. We also...
Research Alert: CFRA Initiates Coverage On Shares Of Robinhood Markets Inc. With A Buy Opinion
Research Alert: CFRA Initiates Coverage On Shares Of Robinhood Markets Inc. With A Buy Opinion
Jul 8, 2025
07:55 AM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We initiate coverage on HOOD with a Buy rating and target of $118, 62.1x our 2026 EPS estimate, reflecting a premium to the company's three-year forward P/E average of 46.5x....
Research Alert: CFRA Retains Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Retains Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Jul 8, 2025
01:00 PM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to $367 from $343 based on our net present value (NPV) analysis. We lift our 2025 EPS estimate to $1.15 from $0.69, as we...
Copyright 2023-2026 - www.financetom.com All Rights Reserved